Status:
COMPLETED
New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Nosocomial Infection
Eligibility:
All Genders
72-90 years
Brief Summary
This study aims to evaluate new dosage of inflammatory markers or new inflammatory markers for the diagnosis of nosocomial bacterial infection. We made the hypothesis that these new dosages or new inf...
Eligibility Criteria
Inclusion
- Newborns \> 72 hours of life hospitalized in neonatal intensive or intermediate care unit presenting a clinical suspicion of NBI
Exclusion
- Early post-operative period ( surgery of less than 48 hours)
- Multiple malformations
- Newborn already included in the study for a previous septic events
- Newborn treated with antibiotics in the last 24 hours
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00701948
Start Date
July 1 2008
End Date
December 1 2013
Last Update
February 5 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pédiatrie 2 - Hôpital d'Enfants CHU de Dijon; 10 - bld Maréchal de Lattre de Tassigny
Dijon, France, 21079
2
Service de Pédiatrie 2 - Hôpital de Hautepierre; 1 - Avenue Molière
Strasbourg, France, 67 092